<!DOCTYPE html>
<html lang="tr"><head>
<script src="sss-tumorleri_files/libs/clipboard/clipboard.min.js"></script>
<script src="sss-tumorleri_files/libs/quarto-html/tabby.min.js"></script>
<script src="sss-tumorleri_files/libs/quarto-html/popper.min.js"></script>
<script src="sss-tumorleri_files/libs/quarto-html/tippy.umd.min.js"></script>
<link href="sss-tumorleri_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="sss-tumorleri_files/libs/quarto-html/light-border.css" rel="stylesheet">
<link href="sss-tumorleri_files/libs/quarto-html/quarto-html.min.css" rel="stylesheet" data-mode="light">
<link href="sss-tumorleri_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.3.340">

  <meta name="author" content="Serdar Balcı">
  <title>Title</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="sss-tumorleri_files/libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="sss-tumorleri_files/libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
  </style>
  <link rel="stylesheet" href="sss-tumorleri_files/libs/revealjs/dist/theme/quarto.css" id="theme">
  <link href="sss-tumorleri_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="sss-tumorleri_files/libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="sss-tumorleri_files/libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="sss-tumorleri_files/libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">

  .callout {
    margin-top: 1em;
    margin-bottom: 1em;  
    border-radius: .25rem;
  }

  .callout.callout-style-simple { 
    padding: 0em 0.5em;
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
    display: flex;
  }

  .callout.callout-style-default {
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
  }

  .callout .callout-body-container {
    flex-grow: 1;
  }

  .callout.callout-style-simple .callout-body {
    font-size: 1rem;
    font-weight: 400;
  }

  .callout.callout-style-default .callout-body {
    font-size: 0.9rem;
    font-weight: 400;
  }

  .callout.callout-titled.callout-style-simple .callout-body {
    margin-top: 0.2em;
  }

  .callout:not(.callout-titled) .callout-body {
      display: flex;
  }

  .callout:not(.no-icon).callout-titled.callout-style-simple .callout-content {
    padding-left: 1.6em;
  }

  .callout.callout-titled .callout-header {
    padding-top: 0.2em;
    margin-bottom: -0.2em;
  }

  .callout.callout-titled .callout-title  p {
    margin-top: 0.5em;
    margin-bottom: 0.5em;
  }
    
  .callout.callout-titled.callout-style-simple .callout-content  p {
    margin-top: 0;
  }

  .callout.callout-titled.callout-style-default .callout-content  p {
    margin-top: 0.7em;
  }

  .callout.callout-style-simple div.callout-title {
    border-bottom: none;
    font-size: .9rem;
    font-weight: 600;
    opacity: 75%;
  }

  .callout.callout-style-default  div.callout-title {
    border-bottom: none;
    font-weight: 600;
    opacity: 85%;
    font-size: 0.9rem;
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-default div.callout-content {
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-simple .callout-icon::before {
    height: 1rem;
    width: 1rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 1rem 1rem;
  }

  .callout.callout-style-default .callout-icon::before {
    height: 0.9rem;
    width: 0.9rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 0.9rem 0.9rem;
  }

  .callout-title {
    display: flex
  }
    
  .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  .callout.no-icon::before {
    display: none !important;
  }

  .callout.callout-titled .callout-body > .callout-content > :last-child {
    margin-bottom: 0.5rem;
  }

  .callout.callout-titled .callout-icon::before {
    margin-top: .5rem;
    padding-right: .5rem;
  }

  .callout:not(.callout-titled) .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  /* Callout Types */

  div.callout-note {
    border-left-color: #4582ec !important;
  }

  div.callout-note .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-note.callout-style-default .callout-title {
    background-color: #dae6fb
  }

  div.callout-important {
    border-left-color: #d9534f !important;
  }

  div.callout-important .callout-icon::before {
    background-image: url('data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAACAAAAAgCAYAAABzenr0AAAAAXNSR0IArs4c6QAAAERlWElmTU0AKgAAAAgAAYdpAAQAAAABAAAAGgAAAAAAA6ABAAMAAAABAAEAAKACAAQAAAABAAAAIKADAAQAAAABAAAAIAAAAACshmLzAAAEKklEQVRYCcVXTWhcVRS+575MJym48A+hSRFr00ySRQhURRfd2HYjk2SSTokuBCkU2o0LoSKKraKIBTcuFCoidGFD08nkBzdREbpQ1EDNIv8qSGMFUboImMSZd4/f9zJv8ibJMC8xJQfO3HPPPef7zrvvvnvviIkpC9nsw0UttFunbUhpFzFtarSd6WJkStVMw5xyVqYTvkwfzuf/5FgtkVoB0729j1rjXwThS7Vio+Mo6DNnvLfahoZ+i/o32lULuJ3NNiz7q6+pyAUkJaFF6JwaM2lUJlV0MlnQn5aTRbEu0SEqHUa0A4AdiGuB1kFXRfVyg5d87+Dg4DL6m2TLAub60ilj7A1Ec4odSAc8X95sHh7+ZRPCFo6Fnp7HfU/fBng/hi10CjCnWnJjsxvDNxWw0NfV6Rv5GgP3I3jGWXumdTD/3cbEOP2ZbOZp69yniG3FQ9z1jD7bnBu9Fc2tKGC2q+uAJOQHBDRiZX1x36o7fWBs7J9ownbtO+n0/qWkvW7UPIfc37WgT6ZGR++EOJyeQDSb9UB+DZ1G6DdLDzyS+b/kBCYGsYgJbSQHuThGKRcw5xdeQf8YdNHsc6ePXrlSYMBuSIAFTGAtQo+VuALo4BX83N190NWZWbynBjhOHsmNfFWLeL6v+ynsA58zDvvAC8j5PkbOcXCMg2PZFk3q8MjI7WAG/Dp9AwP7jdGBOOQkAvlFUB+irtm16I1Zw9YBcpGTGXYmk3kQIC/Cds55l+iMI3jqhjAuaoe+am2Jw5GT3Nbz3CkE12NavmzN5+erJW7046n/CH1RO/RVa8lBLozXk9uqykkGAyRXLWlLv5jyp4RFsG5vGVzpDLnIjTWgnRy2Rr+tDKvRc7Y8AyZq10jj8DqXdnIRNtFZb+t/ZRtXcDiVnzpqx8mPcDWxgARUqx0W1QB9MeUZiNrV4qP+Ehc+BpNgATsTX8ozYKL2NtFYAHc84fG7ndxUPr+AR/iQSns7uSUufAymwDOb2+NjK27lEFocm/EE2WpyIy/Hi66MWuMKJn8RvxIcj87IM5Vh9663ziW36kR0HNenXuxmfaD8JC7tfKbrhFr7LiZCrMjrzTeGx+PmkosrkNzW94ObzwocJ7A1HokLolY+AvkTiD/q1H0cN48c5EL8Crkttsa/AXQVDmutfyku0E7jShx49XqV3MFK8IryDhYVbj7Sj2P2eBxwcXoe8T8idsKKPRcnZw1b+slFTubwUwhktrfnAt7J++jwQtLZcm3sr9LQrjRzz6cfMv9aLvgmnAGvpoaGLxM4mAEaLV7iAzQ3oU0IvD5x9ix3yF2RAAuYAOO2f7PEFWCXZ4C9Pb2UsgDeVnFSpbFK7/IWu7TPTvBqzbGdCHOJQSxiEjt6IyZmxQyEJHv6xyQsYk//moVFsN2zP6fRImjfq7/n/wFDguUQFNEwugAAAABJRU5ErkJggg==');
  }

  div.callout-important.callout-style-default .callout-title {
    background-color: #f7dddc
  }

  div.callout-warning {
    border-left-color: #f0ad4e !important;
  }

  div.callout-warning .callout-icon::before {
    background-image: url('data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAACAAAAAgCAYAAABzenr0AAAAAXNSR0IArs4c6QAAAERlWElmTU0AKgAAAAgAAYdpAAQAAAABAAAAGgAAAAAAA6ABAAMAAAABAAEAAKACAAQAAAABAAAAIKADAAQAAAABAAAAIAAAAACshmLzAAAETklEQVRYCeVWW2gcVRg+58yaTUnizqbipZeX4uWhBEniBaoUX1Ioze52t7sRq6APio9V9MEaoWlVsFasRq0gltaAPuxms8lu0gcviE/FFOstVbSIxgcv6SU7EZqmdc7v9+9mJtNks51NTUH84ed889/PP+cmxP+d5FIbMJmNbpREu4WUkiTtCicKny0l1pIKmBzovF2S+hIJHX8iEu3hZJ5lNZGqyRrGSIQpq15AzF28jgpeY6yk6GVdrfFqdrD6Iw+QlB8g0YS2g7dyQmXM/IDhBhT0UCiRf59lfqmmDvzRt6kByV/m4JjtzuaujMUM2c5Z2d6JdKrRb3K2q6mA+oYVz8JnDdKPmmNthzkAk/lN63sYPgevrguc72aZX/L9C6x09GYyxBgCX4NlvyGUHOKELlm5rXeR1kchuChJt4SSwyddZRXgvwMGvYo4QSlk3/zkHD8UHxwVJA6zjZZqP8v8kK8OWLnIZtLyCAJagYC4rTGW/9Pqj92N/c+LUaAj27movwbi19tk/whRCIE7Q9vyI6yvRpftAKVTdUjOW40X3h5OXsKCdmFcx0xlLJoSuQngnrJe7Kcjm4OMq9FlC7CMmScQANuNvjfP3PjGXDBaUQmbp296S5L4DrpbrHN1T87ZVEZVCzg1FF0Ft+dKrlLukI+/c9ENo+TvlTDbYFvuKPtQ9+l052rXrgKoWkDAFnvh0wTOmYn8R5f4k/jN/fZiCM1tQx9jQQ4ANhqG4hiL0qIFTGViG9DKB7GYzgubnpofgYRwO+DFjh0Zin2m4b/97EDkXkc+f6xYAPX0KK2I/7fUQuwzuwo/L3AkcjugPNixC8cHf0FyPjWlItmLxWw4Ou9YsQCr5fijMGoD/zpdRy95HRysyXA74MWOnscpO4j2y3HAVisw85hX5+AFBRSHt4ShfLFkIMXTqyKFc46xdzQM6XbAi702a7sy04J0+feReMFKp5q9esYLCqAZYw/k14E/xcLLsFElaornTuJB0svMuJINy8xkIYuL+xPAlWRceH6+HX7THJ0djLUom46zREu7tTkxwmf/FdOZ/sh6Q8qvEAiHpm4PJ4a/doJe0gH1t+aHRgCzOvBvJedEK5OFE5jpm4AGP2a8Dxe3gGJ/pAutug9Gp6he92CsSsWBaEcxGx0FHytmIpuqGkOpldqNYQK8cSoXvd+xLxXADw0kf6UkJNFtdo5MOgaLjiQOQHcn+A6h5NuL2s0qsC2LOM75PcF3yr5STuBSAcGG+meA14K/CI21HcS4LBT6tv0QAh8Dr5l93AhZzG5ZJ4VxAqdZUEl9z7WJ4aN+svMvwHHL21UKTd1mqvChH7/Za5xzXBBKrUcB0TQ+Ulgkfbi/H/YT5EptrGzsEK7tR1B7ln9BBwckYfMiuSqklSznIuoIIOM42MQO+QnduCoFCI0bpkzjCjddHPN/F+2Yu+sd9bKNpVwHhbS3LluK/0zgfwD0xYI5dXuzlQAAAABJRU5ErkJggg==');
  }

  div.callout-warning.callout-style-default .callout-title {
    background-color: #fcefdc
  }

  div.callout-tip {
    border-left-color: #02b875 !important;
  }

  div.callout-tip .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-tip.callout-style-default .callout-title {
    background-color: #ccf1e3
  }

  div.callout-caution {
    border-left-color: #fd7e14 !important;
  }

  div.callout-caution .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-caution.callout-style-default .callout-title {
    background-color: #ffe5d0
  }

  </style>
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">

<section id="title-slide" class="quarto-title-block center">
  <h1 class="title">Title</h1>

<div class="quarto-title-authors">
<div class="quarto-title-author">
<div class="quarto-title-author-name">
Serdar Balcı 
</div>
</div>
</div>

</section>
<section class="slide level2">


<img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri0.jpg" class="r-stretch"></section>
<section id="sss-tumorleri" class="title-slide slide level1 center">
<h1>SSS Tümörleri</h1>

</section>

<section id="dr.-serdar-balci" class="title-slide slide level1 center">
<h1>Dr.&nbsp;Serdar BALCI</h1>

</section>

<section id="sss-tümörleri" class="title-slide slide level1 center">
<h1>SSS Tümörleri</h1>
<ul>
<li><strong>SSS tümörlerinin yıllık insidansı</strong>
<ul>
<li><strong>10-17/100,000 intrakraniyel tümörler</strong></li>
<li><strong>1-2/100,000 intraspinal tümörler</strong></li>
</ul></li>
<li><strong>1/2-2/3 primer tümörler</strong></li>
<li><strong>Diğerleri metastatik</strong></li>
<li><strong>Pediatrik tümörlerin %20’si</strong>
<ul>
<li><strong>Daha çok posterior fossada</strong></li>
</ul></li>
<li><strong>Erişkinlerde tümörler daha çok supratentorial</strong></li>
</ul>
</section>

<section id="sss-tümörlerinin-özellikleri" class="title-slide slide level1 center">
<h1>SSS Tümörlerinin Özellikleri</h1>
<ul>
<li><strong>Karsinomlar gibi önceden tespit edilebilen in situ ya da premalign evreleri yok</strong></li>
<li><strong>Düşük dereceli lezyonlar beynin geniş alanlarını infiltre edebilir</strong>
<ul>
<li><strong>Ciddi klinik defisit, rezekte edilemez ve kötü prognoz</strong></li>
</ul></li>
<li><strong>Histolojik sınıflamadan bağımsız olarak anatomik lokalizasyon klinik gidişi etkiler</strong>
<ul>
<li><strong>Lokal kitle etkisi</strong>
<ul>
<li><strong>Benign meningiom medullada kardiyorespiratuar arreste neden olur</strong></li>
</ul></li>
<li><strong>Rezektabilite</strong>
<ul>
<li><strong>Beyin kökü gliomları rezeke edilemez</strong></li>
</ul></li>
</ul></li>
<li><strong>En malign gliomlar bile nadiren SSS dışına çıkar</strong>
<ul>
<li><strong>Lokal infiltrasyon</strong></li>
<li><strong>Subaraknoid alana yayılım</strong></li>
</ul></li>
</ul>
</section>

<section id="sss-tümörleri-1" class="title-slide slide level1 center">
<h1>SSS Tümörleri</h1>
<ul>
<li><strong>SSS tümörleri hemen tüm hücre tiplerinden köken alır</strong></li>
<li><strong>Beyin zarları</strong>
<ul>
<li><strong>Meningiom</strong></li>
</ul></li>
<li><strong>Beyin</strong>
<ul>
<li><strong>Gliom, nöronal tümörler, koroid pleksus tümörleri</strong></li>
</ul></li>
<li><strong>Diğer hücre popülasyonları</strong>
<ul>
<li><strong>Primer SSS lenfomaları, germ hücre tümörleri</strong></li>
</ul></li>
<li><strong>Diğer organlardan</strong>
<ul>
<li><strong>Metastaz</strong></li>
</ul></li>
</ul>
</section>

<section id="sss-tümörleri-sınıflaması" class="title-slide slide level1 center">
<h1>SSS Tümörleri Sınıflaması</h1>

<img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri1.jpg" class="r-stretch"></section>

<section id="hücre-orijinine-göre-sınıflama" class="title-slide slide level1 center">
<h1>Hücre orijinine göre sınıflama</h1>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri2.png"></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri3.png"></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri4.png"></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri5.png"></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri6.png"></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri7.png"></p>
</section>

<section id="ayırıcı-tanı-için-en-önemli-özellikler" class="title-slide slide level1 center">
<h1>Ayırıcı tanı için en önemli özellikler</h1>
<p><strong>Lokalizasyon, lokalizasyon, lokalizasyon…</strong></p>
<p><strong>Yaş</strong></p>
<p><strong>Radyolojik özellikler</strong></p>
<p><strong>Histomorfolojik özellikler</strong></p>
<p><strong>Genetik özellikler</strong></p>
</section>

<section id="sss-tümörlerinin-lokalizasyonu" class="title-slide slide level1 center">
<h1>SSS tümörlerinin lokalizasyonu</h1>
<ul>
<li><strong>Spesifik tümörler spesifik lokalizasyonlarda olur</strong>
<ul>
<li><strong>Serebellum → Medulloblastom</strong></li>
<li><strong>İntraventriküler → Santral Nörositom</strong></li>
</ul></li>
<li><strong>Spesifik yaş grupları</strong>
<ul>
<li><strong>Pediatrik → Medulloblastom, Pilositik astrositom</strong></li>
<li><strong>İleri yaş → Glioblastom, Lenfoma</strong></li>
</ul></li>
</ul>
</section>

<section id="sss-tümörlerinin-yayılımı" class="title-slide slide level1 center">
<h1>SSS tümörlerinin yayılımı</h1>
<p><strong>Beyin tümörlerinin diğer bölgelere yayılımı çok nadir</strong></p>
<p><strong>Spinal subaraknoid tümör yayılımı (ekilimi, seeding)</strong></p>

<img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri8.png" class="r-stretch"><p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
</section>

<section id="sss-tümörlerinin-derecelendirilmesi" class="title-slide slide level1 center">
<h1>SSS tümörlerinin derecelendirilmesi</h1>
<p><strong>Derecelendirme histolojik alt tipe göre yapılır</strong></p>
<p><strong>Grade I tümörler</strong></p>
<p><strong>Grade II tümörler</strong></p>
<p><strong>Grade III tümörler</strong></p>
<p><strong>Grade IV tümörler</strong></p>
<p><strong>Benign, Resection is cure</strong></p>
<p><strong>Progression can be seen</strong></p>
</section>

<section id="gliomlar" class="title-slide slide level1 center">
<h1>GLIOMLAR</h1>

</section>

<section id="gliomlar-1" class="title-slide slide level1 center">
<h1>Gliomlar</h1>
<ul>
<li><strong>Beyin parankim tümörleri</strong></li>
<li><strong>Glial hücelere benzerliklerine göre</strong>
<ul>
<li><strong>Astrositom</strong></li>
<li><strong>Oligodendrogliom</strong></li>
<li><strong>Ependimom</strong></li>
</ul></li>
<li><strong>Diffüz, infiltratif gliomlar</strong>
<ul>
<li><strong>En sık görülen tipler</strong></li>
<li><strong>Astrositik, oligodendroglial ve mikst formlar</strong></li>
</ul></li>
<li><strong>Ependimomlar solid kitleler oluştururlar</strong></li>
</ul>
</section>

<section id="grading-of-cns-gliomas" class="title-slide slide level1 center">
<h1>Grading of CNS gliomas</h1>
<p><strong>Increasing tumor malignancy is associated with more cytologic anaplasia, increased cell density, necrosis, and mitotic activity</strong></p>
<p><strong>Grade I tumors</strong></p>
<p><strong>Grade II tumors</strong></p>
<p><strong>Grade III tumors</strong></p>
<p><strong>Grade IV tumors</strong></p>
</section>

<section id="astrositomlar" class="title-slide slide level1 center">
<h1>Astrositomlar</h1>
<ul>
<li><strong>Pilositik astrositomlar</strong>
<ul>
<li><strong>Derece I</strong></li>
</ul></li>
<li><strong>İnfiltratif gliomlar</strong>
<ul>
<li><strong>Diffüz Astrositom, Derece II</strong>
<ul>
<li><strong>Atipik nükleer özellikler</strong></li>
<li><strong>İnfiltrasyon</strong></li>
</ul></li>
<li><strong>Anaplastik Astrositom, Derece III</strong>
<ul>
<li><strong>Artmış mitoz</strong></li>
</ul></li>
<li><strong>Glioblastom, Derece IV</strong>
<ul>
<li><strong>Nekroz</strong></li>
<li><strong>Mikrovasküler (endotelial) proliferasyon</strong></li>
</ul></li>
</ul></li>
</ul>
</section>

<section id="pilositik-astrositom-derece-i" class="title-slide slide level1 center">
<h1>Pilositik Astrositom, Derece I</h1>
<ul>
<li><strong>Benign tümör</strong></li>
<li><strong>Çocuklar ve genç erişkinler</strong></li>
<li><strong>Lokalizasyon</strong>
<ul>
<li><strong>En sık serebellum</strong></li>
<li><strong>3. ventrikül</strong></li>
<li><strong>Optik yolak</strong></li>
<li><strong>Spinal kord</strong></li>
<li><strong>Serebral hemisferler</strong></li>
</ul></li>
<li><strong>Tümör ile ilişkili kist</strong>
<ul>
<li><strong>Rekürrens olurs da kistik komponentin genişlemesi ile olur</strong></li>
</ul></li>
<li><strong>Hipotalamik tümörler problemli çünkü tümüyle rezeke edilemez</strong></li>
</ul>

<img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri9.png" class="r-stretch"><p><strong>Pilositik Astrositom</strong></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
</section>

<section id="pilositik-astrositom" class="title-slide slide level1 center">
<h1>Pilositik Astrositom</h1>
<ul>
<li><strong>BRAF (serin-threonin kinaz) aktivasyon mutasyonları</strong>
<ul>
<li><strong>Tandem duplikasyon</strong></li>
<li><strong>Nokta mutasyonu (V600E)</strong></li>
</ul></li>
<li><strong>IDH1 ve IDH2 mutasyon yok</strong></li>
</ul>
<p><strong>Kistik</strong></p>
<p><strong>Kist duvarında mural nodül</strong></p>
<p><strong>Eğer solid ise, iyi sınırlı</strong></p>
<p><strong>Bipolar hücreler, ince saçsı uzantılar</strong></p>
<p><strong>GFAP-pozitif</strong></p>
<p><strong>Rozental lifler, eozinofilik granüler cisimcikler, mikrokist</strong></p>
<p><strong>Nekroz ve mitoz çok çok nadir</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri10.png"></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri11.png"></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri12.png"></p>
</section>

<section id="diffüz-astrositomlar" class="title-slide slide level1 center">
<h1>Diffüz astrositomlar</h1>
<ul>
<li><strong>Erişkin gliomların %80’i</strong></li>
<li><strong>4-6. dekad</strong></li>
<li><strong>Genellikle serebral hemisferlerde</strong></li>
<li><strong>Klinik bilgi ve bulgular</strong>
<ul>
<li><strong>Nöbet</strong></li>
<li><strong>Başağrısı</strong></li>
<li><strong>Lokalizasyona bağlı nörolojik defisitler</strong></li>
</ul></li>
</ul>
</section>

<section id="diffuse-astrocytoma" class="title-slide slide level1 center">
<h1>Diffuse Astrocytoma</h1>
<ul>
<li><strong>Spectrum of histologic differentiation that correlates well with clinical course and outcome</strong>
<ul>
<li><strong>well-differentiated astrocytoma (grade II/IV)</strong></li>
<li><strong>anaplastic astrocytoma (grade III/IV)</strong></li>
<li><strong>glioblastoma (grade IV/IV)</strong></li>
</ul></li>
</ul>
<p><strong>Infiltrating pontine glioma (astrocytoma)</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri13.png"></p>
<p>Autopsy Pathology: A Manual and Atlas</p>
<p><strong>Diffüz infiltratif astrositom</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri14.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri15.png"></p>
<p><strong>İyi diferansiye astrositomlar belirsiz sınırlı, gri, infiltratif tümörlerdir. Ayrı bir kitle oluşturmadan infiltratif oalrak büyür ve normal dokuların yapısını ortadan kaldırır</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri16.png"></p>
<p><strong>Makroskopik olarak görünen sınır ötesine de uzanım mutlaka vardır</strong></p>
<p><strong>Kesit yüzü sert, yumuşak veya jelatinöz</strong></p>
<p><strong>Kistik dejenerasyon görülebilir</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri17.png"></p>
<p><strong>Clinical Neuropathology Text and Color Atlas</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri18.png"></p>
<p><strong>Practical Surgical Neuropathology</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri19.png"></p>
<p><strong>Brain Tumor Pathol (2011) 28:177–183</strong></p>
</section>

<section id="diffüz-astrositom" class="title-slide slide level1 center">
<h1>Diffüz astrositom</h1>
<ul>
<li><strong>İyi diferansiye astrositomlar uuzn yıllar statik kalabilir</strong>
<ul>
<li><strong>Progresyon olduğunda, ortalama sağkalım 5 yıldan fazla</strong></li>
</ul></li>
<li><strong>Hızlı klinik bozulma, anaplastik özelliklerin ortaya çıkması ve hızlı tümör büyümesi ile korele</strong></li>
<li><strong>Tümörlerin dereceleri artabilir</strong>
<ul>
<li><strong>İyi diferansiye, Grade II → Anaplastik astrositom, grade III → Glioblastom, grade IV</strong></li>
</ul></li>
<li><strong>Glioblastoma ait histolojik özellikler belirgin olduğunda sağkalım çok kötü</strong>
<ul>
<li><strong>Rezeksiyon, radyoterapi ve kemoterapi ile ortanca sağkalım 15 ay</strong></li>
</ul></li>
</ul>

<img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri20.png" class="r-stretch"><p><strong>Brain Tumor Pathol (2011) 28:177–183</strong></p>
</section>

<section id="defects-in-tricyclic-carbon-cycle" class="title-slide slide level1 center">
<h1>Defects in tricyclic carbon cycle</h1>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri21.png"></p>
<p><strong>Isocitrate dehydrogenase mutasyonları yan ürünlerin birikimine neden olur</strong></p>
<p><strong>SSS tümörlerinde yakın zamanda bulunan en önemli mutasyon</strong></p>
<p><strong>Cancer Cell. 2010 Jan 19;17(1):7-9</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri22.png"></p>
<p><strong>N Engl J Med 2009;360:765-73.</strong></p>
</section>

<section id="iyi-diferansiye-astrositom" class="title-slide slide level1 center">
<h1>İyi diferansiye astrositom</h1>
<p><strong>Glial hücre sayısında hafif orta artış</strong></p>
<p><strong>Değişken nükleer pleomorfizm</strong></p>
<p><strong>Zeminde ince, GFAP pozitif gliofibriler ağ</strong></p>
<p><strong>Normal doku ve tümör geçişi net değil</strong></p>
<p><strong>Neoplastik hücreler ana tümör kitlesinin santimetrelerce uzağında olabilir</strong></p>
</section>

<section id="anaplastik-astrositomlar-derece-iii" class="title-slide slide level1 center">
<h1>Anaplastik astrositomlar, Derece III</h1>
<p><strong>Selülarite daha belirgin</strong></p>
<p><strong>Daha belirgin nükleer pleomorfizm</strong></p>
<p><strong>Mitotik figürlerin görülmesi</strong></p>

<img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri23.png" class="r-stretch"><p><strong>Practical Surgical Neuropathology</strong></p>
</section>

<section id="glioblastom-derece-iv" class="title-slide slide level1 center">
<h1>Glioblastom, Derece IV</h1>
<ul>
<li><strong>p53 ve Rb tümör süpresör yolaklarında fonksiyon kaybı mutasyonları</strong></li>
<li><strong>Onkojenik PI3K yolaklarında fonksiyon kazanıkm mutasyonları</strong></li>
<li><strong>Düşük dereceli astrositomlarda ve bunlardan gelişen glioblastomlarda isocitrate dehydrogenase (IDH1 and IDH2) mutasyonları</strong>
<ul>
<li><strong>İmmünohistokimya ile tanısal olarak da kullanılıyor</strong></li>
</ul></li>
</ul>
</section>

<section id="glioblastom" class="title-slide slide level1 center">
<h1>Glioblastom</h1>
<ul>
<li><strong>Anaplastik astrositom özellikleri VE</strong></li>
<li><strong>Nekroz</strong>
<ul>
<li><strong>Psödopalizatlanma</strong></li>
<li><strong>Coğrafi</strong></li>
</ul></li>
<li><strong>Vasküler proliferasyon</strong>
<ul>
<li><strong>Mikrovasküler proliferasyon</strong></li>
<li><strong>Vasküler endotelyal proliferasyon</strong></li>
<li><strong>Glomeruloid vasküler proliferasyon</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri24.png"></p>
<p><strong>Glioblastom</strong></p>
<p><strong>Nekrotik, hemorajik, infiltratif kitle</strong></p>
<ul>
<li><strong>Makroskopik görünümde bölgesel farklılıklar karakteristiktir:</strong></li>
<li><strong>Sert ve beyaz</strong></li>
<li><strong>Yumuşak ve sarı</strong>
<ul>
<li><strong>Nekroz</strong></li>
</ul></li>
<li><strong>Kistik dejenerasyon ve kanama</strong></li>
</ul>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>Glioblastoma multiforme</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri25.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri26.png"></p>
<p><strong>Glioblastom</strong></p>
<p><strong>Selüler tümör, nekroz ve psödopalizatlanma dizilimi</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri27.png"></p>
<p><strong>Clinical Neuropathology Text and Color Atlas</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri28.png"></p>
<p><strong>Practical Surgical Neuropathology</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri29.png"></p>
<p><strong>Practical Surgical Neuropathology</strong></p>
</section>

<section id="oligodendrogliom" class="title-slide slide level1 center">
<h1>OLIGODENDROGLIOM</h1>

</section>

<section id="oligodendrogliom-1" class="title-slide slide level1 center">
<h1>Oligodendrogliom</h1>
<ul>
<li><strong>Gliomların %5-15’i</strong></li>
<li><strong>4-5. dekad</strong></li>
<li><strong>Uzun yıllar süren nörolojik bulgular, sıklıkla nöbet</strong></li>
<li><strong>Çoğunlukla serebral hemisferlerde</strong>
<ul>
<li><strong>Frontal ve temporal lob</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri30.png"></p>
<p><strong>Oligodendrogliom: Tümör hücreleri yuvarlak oval çekirdekli, sitoplazmik halo</strong></p>
<p><strong>Damarlar ince</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<ul>
<li><strong>Benzer dereceli astrositomdan daha iyi prognozlu</strong></li>
<li><strong>Cerrahi, kemoterapi ve radyoterapi sonrası</strong>
<ul>
<li><strong>İyi diferansiye (WHO grade II) oligodendrogliomlarda ortalama sağkalım 10-20 yıl</strong></li>
<li><strong>Anaplastik (WHO grade III) oligodendrogliomlarda 5-10 yıl</strong></li>
</ul></li>
</ul>
<p><strong>1p ve 19q kromozomların kaybı</strong></p>
<p><strong>1p ve 19q kaybı tipik olarak birlikte olur</strong></p>
<p><strong>1p ve 19q kaybı gösteren tümörlerde kemoterapi ve radyoterapiye cevap çok daha iyi</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri31.png"></p>
</section>

<section id="iyi-diferansiye-oligodendrogliomlar-who-grade-iiiv" class="title-slide slide level1 center">
<h1>İyi diferansiye oligodendrogliomlar(WHO grade II/IV)</h1>
<ul>
<li><strong>Infiltratif tümörler</strong></li>
<li><strong>Jelatinöz, gri kitleler</strong></li>
<li><strong>Kist, fokal kanama ve kalsifikasyon</strong></li>
<li><strong>Tabakalar halinde regüler hücreler</strong>
<ul>
<li><strong>Oligodendroglial hücrelere benzer yuvarlak nükleus, ince granüler görünümde kromatin</strong></li>
<li><strong>Şeffaf sitoplazmik halo</strong></li>
</ul></li>
<li><strong>İnce anastomoz yapan kapillerler</strong></li>
<li><strong>Kalsifikasyon</strong>
<ul>
<li><strong>Tümörlerin %90’ında var</strong></li>
<li><strong>Mikroskopik ve makroskopik birikimler</strong></li>
</ul></li>
<li><strong>Mitozu genelde tespit etmek zor</strong></li>
</ul>
</section>

<section id="anaplastic-oligodendroglioma-who-grade-iiiiv" class="title-slide slide level1 center">
<h1>Anaplastic oligodendroglioma (WHO grade III/IV)</h1>
<p><strong>More aggressive subtype</strong></p>
<p><strong>Higher cell density</strong></p>
<p><strong>Nuclear anaplasia</strong></p>
<p><strong>Mitotic activity</strong></p>
</section>

<section id="ependimom" class="title-slide slide level1 center">
<h1>EPENDİMOM</h1>

</section>

<section id="ependimom-1" class="title-slide slide level1 center">
<h1>Ependimom</h1>
<ul>
<li><strong>Oluşum yeri</strong>
<ul>
<li><strong>Ependim döşeli ventriküler sistem</strong></li>
<li><strong>Central canal</strong></li>
</ul></li>
<li><strong>İlk iki dekad</strong>
<ul>
<li><strong>4. ventrikül</strong></li>
<li><strong>Bu yaş grubundaki beyin tümörlerinin %5-10’u</strong></li>
</ul></li>
<li><strong>Erişkinler</strong>
<ul>
<li><strong>Spinal kord en sık oluşum yeri</strong></li>
<li><strong>Nörofibromatozis tip 2</strong></li>
</ul></li>
<li><strong>Tümüyle çıkarılan supratentoryal ve spinal ependimomların prognozu posterior fossa tümörlerinden daha iyi</strong></li>
</ul>
<p><strong>4. ventrikül</strong></p>
<p><strong>Solid veya papiller kitle</strong></p>
<p><strong>Ventrikül tabanından köken alır</strong></p>

<img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri32.png" class="r-stretch"></section>

<section id="ependymoma" class="title-slide slide level1 center">
<h1>Ependymoma</h1>
<ul>
<li><strong>Cells with regular, round to oval nuclei and abundant granular chromatin</strong></li>
<li><strong>Between the nuclei a variably dense fibrillary background</strong></li>
<li><strong>Round or elongated structures</strong>
<ul>
<li><strong>rosettes, canals</strong></li>
<li><strong>resemble the embryologic ependymal canal</strong></li>
</ul></li>
<li><strong>Long, delicate processes extending into a lumen</strong></li>
<li><strong>Perivascular pseudorosettes</strong>
<ul>
<li><strong>tumor cells are arranged around vessels with an intervening zone containing thin ependymal processes</strong></li>
</ul></li>
</ul>
</section>

<section id="anaplastic-ependymoma" class="title-slide slide level1 center">
<h1>Anaplastic ependymoma</h1>
<p><strong>Increased cell density</strong></p>
<p><strong>High mitotic rates</strong></p>
<p><strong>Necrosis</strong></p>
<p><strong>Less evident ependymal differentiation</strong></p>

<img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri33.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="neuronal-tumors" class="title-slide slide level1 center">
<h1>NEURONAL TUMORS</h1>

</section>

<section id="neuronal-tümörler" class="title-slide slide level1 center">
<h1>Neuronal Tümörler</h1>
<p><strong>Santral Nörositom</strong></p>
<p><strong>Gangliogliom</strong></p>
<p><strong>Dysembryoplastic neuroepithelial tumor (DNET)</strong></p>
</section>

<section id="central-neurocytoma" class="title-slide slide level1 center">
<h1>Central neurocytoma</h1>
<p><strong>Low-grade neoplasm</strong></p>
<p><strong>Within and adjacent to the ventricular system</strong></p>
<p><strong>Most commonly the lateral or third ventricles</strong></p>
<p><strong>Evenly spaced, round, uniform nuclei</strong></p>
<p><strong>Islands of neuropil</strong></p>
</section>

<section id="ganglioglioma" class="title-slide slide level1 center">
<h1>Ganglioglioma</h1>
<ul>
<li><strong>Manifest with seizures</strong></li>
<li><strong>Slow-growing</strong></li>
<li><strong>Mixed tumor</strong>
<ul>
<li><strong>glial elements</strong>
<ul>
<li><strong>low-grade astrocytoma</strong></li>
</ul></li>
<li><strong>mature-appearing neurons</strong></li>
</ul></li>
<li><strong>Glial component occasionally becomes anaplastic</strong>
<ul>
<li><strong>then progresses rapidly</strong></li>
</ul></li>
</ul>
</section>

<section id="dysembryoplastic-neuroepithelial-tumor-dnet" class="title-slide slide level1 center">
<h1>Dysembryoplastic neuroepithelial tumor (DNET)</h1>
<ul>
<li><strong>Low-grade childhood tumor</strong></li>
<li><strong>Grows slowly</strong></li>
<li><strong>Relatively good prognosis after resection</strong></li>
<li><strong>Often manifests as a seizure disorder</strong></li>
<li><strong>Typically located in the superficial temporal lobe</strong></li>
<li><strong>Consists of small round neuronal cells</strong>
<ul>
<li><strong>arranged in columns</strong></li>
<li><strong>around central cores of processes</strong></li>
</ul></li>
<li><strong>Typically form multiple discrete intracortical nodules</strong>
<ul>
<li><strong>myxoid background</strong></li>
</ul></li>
<li><strong>Well-differentiated “floating” neurons within pools of mucopolysaccharide-rich myxoid fluid</strong></li>
</ul>
</section>

<section id="embriyonal-primitif-neoplaziler" class="title-slide slide level1 center">
<h1>EMBRİYONAL (PRIMITIF) NEOPLAZİLER</h1>

</section>

<section id="embryonal-primitive-neoplasms" class="title-slide slide level1 center">
<h1>Embryonal (Primitive) Neoplasms</h1>
<ul>
<li><strong>Neuroectodermal origin</strong></li>
<li><strong>Primitive “small round cell” appearance</strong>
<ul>
<li><strong>reminiscent of normal progenitor cells encountered in the developing CNS</strong></li>
</ul></li>
<li><strong>Differentiation is often limited</strong></li>
<li><strong>May progress along multiple lineages</strong></li>
</ul>
</section>

<section id="medulloblastom" class="title-slide slide level1 center">
<h1>Medulloblastom</h1>
<p><strong>En sık embriyonel tümör</strong></p>
<p><strong>Pediatrik beyin tümörlerinin %20’si</strong></p>
<p><strong>Serebellum</strong></p>
<p><strong>Küçük yuvarlak hücreli malign tümör</strong></p>
<ul>
<li><strong>Most common Embryonal (Primitive) Neoplasm</strong></li>
<li><strong>20% of pediatric brain tumors</strong></li>
<li><strong>Cerebellum</strong></li>
<li><strong>Neuronal and glial markers are nearly always expressed</strong></li>
<li><strong>Highly malignant</strong>
<ul>
<li><strong>Prognosis for untreated patients is dismal</strong></li>
<li><strong>Exquisitely radiosensitive</strong></li>
<li><strong>Total excision, chemotherapy, and irradiation, the 5-year survival rate may be as high as 75%</strong></li>
</ul></li>
<li><strong>Primitive neuroectodermal tumors (PNETs)</strong>
<ul>
<li><strong>Tumors of similar histologic type and a poor degree of differentiation elsewhere in the nervous system</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri34.png"></p>
<p><strong>Located in the midline of the cerebellum</strong></p>
<p><strong>Lateral tumors occur more often in adults</strong></p>
<p><strong>Often well circumscribed, gray, and friable</strong></p>
<p><strong>May extend to the surface of the cerebellar folia and involve the leptomeninges</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri35.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri36.png"></p>
<p><strong>Extremely cellular</strong></p>
<p><strong>Sheets of anaplastic (small blue) cells</strong></p>
<p><strong>Small, with little cytoplasm</strong></p>
<p><strong>Hyperchromatic nuclei</strong></p>
<p><strong>Abundant mitosis</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri37.png"></p>
<p><strong>Focal neuronal differentiation</strong></p>
<p><strong>Homer Wright or neuroblastic rosette</strong></p>
<p><strong>Resembles the rosettes in neuroblastomas</strong></p>
<p><strong>Primitive tumor cells surrounding central neuropil</strong></p>
<p><strong>-delicate pink material formed by neuronal processes</strong></p>
</section>

<section id="medulloblastom-genetiği" class="title-slide slide level1 center">
<h1>Medulloblastom genetiği</h1>
<ul>
<li><strong>MYC amplifikasyonu</strong>
<ul>
<li><strong>Kötü klinik gidiş</strong></li>
</ul></li>
<li><strong>WNT sinyal yolağı</strong>
<ul>
<li><strong>Daha iyi gidiş</strong></li>
</ul></li>
<li><strong>Sonic hedgehog (shh) yolağı</strong>
<ul>
<li><strong>Klinik gidişle ilişkisi net değil</strong></li>
</ul></li>
</ul>
</section>

<section id="genetic-of-medulloblastoma" class="title-slide slide level1 center">
<h1>Genetic of medulloblastoma</h1>
<ul>
<li><strong>Morphologically similar tumors commonly exhibit distinct alterations</strong></li>
<li><strong>There is a relationship between the underlying mutations and outcome</strong></li>
<li><strong>MYC amplification</strong>
<ul>
<li><strong>associated with poor outcomes</strong></li>
</ul></li>
<li><strong>WNT signaling pathway</strong>
<ul>
<li><strong>have a more favorable course</strong></li>
</ul></li>
<li><strong>Sonic hedgehog (shh) pathway</strong>
<ul>
<li><strong>has a critical role in tumorigenesis but an uncertain relationship to outcome</strong></li>
</ul></li>
</ul>
</section>

<section id="lenfomalar" class="title-slide slide level1 center">
<h1>LENFOMALAR</h1>

</section>

<section id="primary-cns-lymphoma" class="title-slide slide level1 center">
<h1>Primary CNS Lymphoma</h1>
<ul>
<li><strong>Mostly diffuse large B cell lymphoma</strong></li>
<li><strong>2% of extranodal lymphomas</strong></li>
<li><strong>1% of intracranial tumors</strong></li>
<li><strong>Most common CNS neoplasm in immunosuppressed persons</strong>
<ul>
<li><strong>nearly always positive for the oncogenic Epstein-Barr virus</strong></li>
</ul></li>
<li><strong>Nonimmunosuppressed populations</strong>
<ul>
<li><strong>age spectrum is relatively wide</strong></li>
<li><strong>incidence increasing &gt;60 years of age</strong></li>
</ul></li>
<li><strong>Aggressive disease</strong>
<ul>
<li><strong>relatively poor response to chemotherapy compared with peripheral lymphomas</strong></li>
</ul></li>
</ul>
</section>

<section id="primer-sss-lenfoması" class="title-slide slide level1 center">
<h1>Primer SSS lenfoması</h1>
<p><strong>Çoğunlukla diffüz büyük B hücreli lenfoma</strong></p>
</section>

<section id="primary-cns-lymphoma-1" class="title-slide slide level1 center">
<h1>Primary CNS Lymphoma</h1>
<ul>
<li><strong>Multiple tumor nodules within the brain parenchyma</strong></li>
<li><strong>Involvement outside of the CNS is an uncommon late complication</strong></li>
<li><strong>Lymphoma originating outside the CNS rarely spreads to the brain parenchyma</strong>
<ul>
<li><strong>when it happens, within the CSF or involvement of the meninges</strong></li>
</ul></li>
<li><strong>Often involve deep gray structures</strong></li>
<li><strong>Also white matter and the cortex</strong></li>
<li><strong>Periventricular spread is common</strong></li>
<li><strong>Relatively well defined as compared with glial neoplasms</strong>
<ul>
<li><strong>not as discrete as metastases</strong></li>
</ul></li>
<li><strong>EBV-associated tumors</strong>
<ul>
<li><strong>extensive areas of necrosis</strong></li>
</ul></li>
<li><strong>Nearly always aggressive large B-cell lymphomas</strong>
<ul>
<li><strong>rarely other histologic types</strong></li>
</ul></li>
<li><strong>Malignant cells accumulate around blood vessels</strong></li>
<li><strong>Infiltrate the surrounding brain parenchyma</strong></li>
</ul>
</section>

<section id="germ-cell-tumors" class="title-slide slide level1 center">
<h1>GERM CELL TUMORS</h1>

</section>

<section id="primary-brain-germ-cell-tumors" class="title-slide slide level1 center">
<h1>Primary brain germ cell tumors</h1>
<ul>
<li><strong>Occur along the midline</strong>
<ul>
<li><strong>Most commonly in the pineal and the suprasellar regions</strong></li>
</ul></li>
<li><strong>0.2-1% of brain tumors in European</strong></li>
<li><strong>10% of brain tumors in Japanese</strong></li>
<li><strong>Young</strong>
<ul>
<li><strong>90%, during the first 2 decades of life</strong></li>
</ul></li>
<li><strong>Pineal region show a strong male predominance</strong></li>
<li><strong>Germinoma</strong>
<ul>
<li><strong>Most common primary CNS germ cell tumor</strong></li>
<li><strong>resembles testicular seminoma</strong></li>
</ul></li>
<li><strong>Metastatic gonadal germ cell tumors also occur</strong></li>
</ul>
</section>

<section id="meningiom" class="title-slide slide level1 center">
<h1>MENINGIOM</h1>

</section>

<section id="meningioma" class="title-slide slide level1 center">
<h1>Meningioma</h1>
<p><strong>Benign</strong></p>
<p><strong>Araknoid meningotelyal hücre kökenli</strong></p>
<p><strong>Duraya yapışık</strong></p>
<ul>
<li><strong>Predominantly benign tumors</strong></li>
<li><strong>Arise from arachnoid meningothelial cells</strong></li>
<li><strong>Usually occur in adults</strong></li>
<li><strong>Often attached to the dura</strong></li>
<li><strong>Found along any of the external surfaces of the brain</strong></li>
<li><strong>Within the ventricular system</strong>
<ul>
<li><strong>arise from the stromal arachnoid cells of the choroid plexus</strong></li>
</ul></li>
<li><strong>Sympotoms</strong>
<ul>
<li><strong>vague nonlocalizing symptoms</strong></li>
<li><strong>focal findings compression of adjacent brain</strong></li>
</ul></li>
<li><strong>Most meningiomas are easily separable from underlying brain</strong>
<ul>
<li><strong>some tumors infiltrate the brain</strong></li>
<li><strong>increased risk of recurrence</strong></li>
</ul></li>
<li><strong>Overall prognosis</strong>
<ul>
<li><strong>lesion size and location</strong></li>
<li><strong>surgical accessibility</strong></li>
<li><strong>histologic grade</strong></li>
</ul></li>
<li><strong>Neurofibromatosis type 2 (NF2)</strong>
<ul>
<li><strong>Multiple meningiomas</strong></li>
<li><strong>eighth-nerve schwannomas</strong></li>
<li><strong>glial tumors</strong></li>
</ul></li>
<li><strong>Half of meningiomas not associated with NF2</strong>
<ul>
<li><strong>acquired loss-of-function mutations in the NF2 TSG on 22q</strong></li>
</ul></li>
<li><strong>Mutations found in all grades of meningioma</strong>
<ul>
<li><strong>involved with tumor initiation</strong></li>
</ul></li>
<li><strong>Mutations in NF2 are more common in:</strong>
<ul>
<li><strong>fibroblastic, transitional, and psammomatous growth pattern</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri38.png"></p>
<p><strong>Meningioma</strong></p>
<p><strong>WHO grade I/IV</strong></p>
<p><strong>well-defined dura-based masses</strong></p>
<p><strong>compress the brain but do not invade it</strong></p>
<p><strong>Extension into the overlying bone may be present</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>Parasagittal meningioma</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri39.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><strong>Intraosseous meningioma</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri40.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
</section>

<section id="histologic-patterns-of-meningioma" class="title-slide slide level1 center">
<h1>Histologic patterns of Meningioma</h1>
<ul>
<li><strong>Syncytial</strong>
<ul>
<li><strong>whorled clusters of cells without visible cell membranes that sit in tight groups</strong></li>
</ul></li>
<li><strong>Fibroblastic</strong>
<ul>
<li><strong>elongated cells and abundant collagen deposition between them</strong></li>
</ul></li>
<li><strong>Transitional</strong>
<ul>
<li><strong>shares features of the syncytial and fibroblastic types</strong></li>
</ul></li>
<li><strong>Psammomatous</strong>
<ul>
<li><strong>numerous psammoma bodies</strong></li>
</ul></li>
<li><strong>Secretory</strong>
<ul>
<li><strong>gland-like PAS-positive eosinophilic secretions known as pseudopsammoma bodies</strong></li>
</ul></li>
</ul>

<img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri41.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="atypical-meningiomas-who-grade-iiiv" class="title-slide slide level1 center">
<h1>Atypical meningiomas(WHO grade II/IV)</h1>
<p><strong>prominent nucleoli</strong></p>
<p><strong>increased cellularity</strong></p>
<p><strong>pattern-less growth</strong></p>
<p><strong>higher mitotic rate</strong></p>
<p><strong>More aggressive local growth</strong></p>
<p><strong>Higher rate of recurrence</strong></p>
<p><strong>Require therapy in addition to surgery</strong></p>
</section>

<section id="anaplastic-malignant-meningiomas-who-grade-iiiiv" class="title-slide slide level1 center">
<h1>Anaplastic (malignant) meningiomas(WHO grade III/IV)</h1>
<p><strong>Highly aggressive tumors</strong></p>
<p><strong>May resemble a high-grade sarcoma or carcinoma</strong></p>
<p><strong>usually some histologic evidence of a meningothelial cell origin</strong></p>
</section>

<section id="metastatik-tümörler" class="title-slide slide level1 center">
<h1>METASTATIK TÜMÖRLER</h1>

</section>

<section id="metastatic-tumors" class="title-slide slide level1 center">
<h1>Metastatic Tumors</h1>
<p><strong>Mostly carcinomas</strong></p>
<p><strong>1/4-1/2 of intracranial tumors</strong></p>
<p><strong>Most common primary sites</strong></p>
<p><strong>Lung, breast, skin (melanoma), kidney, and gastrointestinal tract</strong></p>
<p><strong>Form sharply demarcated masses</strong></p>
<p><strong>Often at the gray-white junction, and elicit edema</strong></p>
<p><strong>The boundary between tumor and brain parenchyma is sharp at the microscopic level as well, with surrounding reactive gliosis</strong></p>
<p><strong>Direct and localized effects</strong></p>
</section>

<section id="section" class="title-slide slide level1 center">
<h1></h1>
<p><strong>Metastatic spread of brain tumors to other regions of the body is rare</strong></p>
<p><strong>Brain is not protected against spread of distant tumors</strong></p>
<p><strong>Carcinomas are the dominant type of systemic tumors that metastasize to the nervous system</strong></p>

<img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri42.png" class="r-stretch"><p><strong>Metastatic melanoma</strong></p>
<p><strong>Metastatic lesions are distinguished grossly from most primary central nervous system tumors by their multicentricity and well-demarcated margins</strong></p>
<p><strong>The dark color of the tumor nodules in this specimen is due to the presence of melanin</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="paraneoplastic-syndromes" class="title-slide slide level1 center">
<h1>Paraneoplastic syndromes</h1>
<ul>
<li><strong>Subacute cerebellar degeneration</strong>
<ul>
<li><strong>result in ataxia</strong></li>
<li><strong>destruction of Purkinje cells, gliosis, and a mild inflammatory infiltrate</strong></li>
</ul></li>
<li><strong>Limbic encephalitis</strong>
<ul>
<li><strong>subacute dementia</strong></li>
<li><strong>perivascular inflammatory cells, microglial nodules, some neuronal loss, and gliosis, all centered in the medial temporal lobe</strong></li>
</ul></li>
<li><strong>Subacute sensory neuropathy</strong>
<ul>
<li><strong>altered pain sensation</strong></li>
<li><strong>loss of sensory neurons from dorsal root ganglia, in association with inflammation</strong></li>
</ul></li>
<li><strong>Syndrome of rapid-onset psychosis, catatonia, epilepsy, and coma</strong>
<ul>
<li><strong>associated with ovarian teratoma</strong></li>
<li><strong>antibodies against the N-methyl-d-aspartate (NMDA) receptor</strong></li>
</ul></li>
</ul>
</section>

<section id="ailesel-tümör-sendromlari" class="title-slide slide level1 center">
<h1>AILESEL TÜMÖR SENDROMLARI</h1>

</section>

<section id="ailesel-tümör-sendromları" class="title-slide slide level1 center">
<h1>Ailesel tümör sendromları</h1>
<ul>
<li><strong>Tuberous Sclerosis (TSC)</strong>
<ul>
<li><strong>Kortikal tüberler</strong></li>
</ul></li>
<li><strong>von Hippel–Lindau Hastalığı</strong>
<ul>
<li><strong>Serebellar Hemanjioblastomlar</strong></li>
</ul></li>
</ul>
</section>

<section id="tuberous-sclerosis-tsc" class="title-slide slide level1 center">
<h1>Tuberous Sclerosis (TSC)</h1>
<ul>
<li><strong>Autosomal dominant</strong></li>
<li><strong>Development of hamartomas and benign neoplasms involving the brain and other tissues</strong></li>
<li><strong>CNS hamartomas</strong>
<ul>
<li><strong>cortical tubers</strong></li>
<li><strong>subependymal hamartomas</strong></li>
<li><strong>tumefactive form known as subependymal giant cell astrocytoma</strong></li>
</ul></li>
<li><strong>Proximity to the foramen of Monro</strong>
<ul>
<li><strong>present acutely with obstructive hydrocephalus</strong></li>
<li><strong>requires surgical intervention and/or therapy with an mTOR inhibitor</strong></li>
</ul></li>
<li><strong>Seizures</strong>
<ul>
<li><strong>associated with cortical tubers</strong></li>
<li><strong>difficult to control with antiepileptic drugs</strong></li>
</ul></li>
<li><strong>Extracerebral lesions</strong>
<ul>
<li><strong>renal angiomyolipomas</strong></li>
<li><strong>retinal glial hamartomas</strong></li>
<li><strong>pulmonary lymphangiomyomatosis</strong></li>
<li><strong>cardiac rhabdomyomas</strong></li>
<li><strong>Cysts</strong>
<ul>
<li><strong>liver, kidneys, and pancreas</strong></li>
</ul></li>
<li><strong>Cutaneous lesions</strong>
<ul>
<li><strong>angiofibromas, leathery thickenings in localized patches (shagreen patches), hypopigmented areas (ash leaf patches), and subungual fibromas</strong></li>
</ul></li>
</ul></li>
<li><strong>TSC1</strong>
<ul>
<li><strong>encodes hamartin</strong></li>
</ul></li>
<li><strong>TSC2</strong>
<ul>
<li><strong>encodes tuberin</strong></li>
</ul></li>
<li><strong>Two TSC proteins form a dimeric complex</strong>
<ul>
<li><strong>negatively regulates mTOR, a kinase that “senses” the cell’s nutrient status and regulates cellular metabolism</strong></li>
</ul></li>
<li><strong>Loss of either protein leads to increased mTOR activity</strong>
<ul>
<li><strong>Disrupts nutritional signaling and increases cell growth</strong></li>
</ul></li>
<li><strong>Cortical hamartomas</strong></li>
<li><strong>Firmer than normal cortex</strong></li>
<li><strong>Likened in appearance to potatoes</strong>
<ul>
<li><strong>“tubers”</strong></li>
</ul></li>
<li><strong>Composed of haphazardly arranged large neurons</strong></li>
<li><strong>Lack the normal cortical laminar architecture</strong></li>
<li><strong>Cells exhibit a mixture of glial and neuronal features</strong>
<ul>
<li><strong>large vesicular nuclei with nucleoli (like neurons)</strong></li>
<li><strong>abundant eosinophilic cytoplasm (like gemistocytic astrocytes)</strong></li>
<li><strong>Similar cells are present in the subependymal nodules</strong></li>
</ul></li>
</ul>
</section>

<section id="von-hippellindau-disease" class="title-slide slide level1 center">
<h1>von Hippel–Lindau Disease</h1>
<ul>
<li><strong>Autosomal dominant disorder</strong></li>
<li><strong>Hemangioblastoma</strong>
<ul>
<li><strong>cerebellar hemispheres, retina, and, less commonly, the brain stem, spinal cord, and nerve roots</strong></li>
</ul></li>
<li><strong>Cysts</strong>
<ul>
<li><strong>pancreas, liver, and kidneys</strong></li>
</ul></li>
<li><strong>Renal cell carcinoma</strong></li>
<li><strong>Frequency is 1/30,000-40,000</strong></li>
<li><strong>Therapy is directed at the symptomatic neoplasms</strong>
<ul>
<li><strong>surgical resection of cerebellar tumors and laser ablation of retinal tumors</strong></li>
</ul></li>
<li><strong>Tumor suppressor VHL</strong></li>
<li><strong>Encodes a protein that is part of a ubiquitin-ligase complex</strong></li>
<li><strong>Targets the transcription factor hypoxia-inducible factor (HIF) for degradation</strong></li>
<li><strong>Lost all VHL protein function</strong></li>
<li><strong>Express high levels of HIF</strong></li>
<li><strong>Expression of VEGF, various growth factors</strong></li>
<li><strong>Expression of erythropoietin</strong>
<ul>
<li><strong>paraneoplastic polycythemia</strong></li>
</ul></li>
<li><strong>Cerebellar capillary hemangioblastoma</strong>
<ul>
<li><strong>Highly vascular neoplasm</strong></li>
<li><strong>Mural nodule</strong></li>
<li><strong>Large, fluid-filled cyst</strong></li>
<li><strong>Numerous capillary-sized or somewhat larger thin-walled vessels</strong></li>
<li><strong>Intervening stromal cells with vacuolated, lightly PAS-positive, lipid-rich cytoplasm</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri43.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri44.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><span style="color:#E72E09">Distribution of CNS Tumors</span></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri45.jpg"></p>
<p><strong>A pilocytic astrocytoma of the cerebellum in a child. </strong></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri46.jpg"></p>
<p><strong>Glioma of the brainstem – pilocytic astrocytoma</strong></p>
</section>

<section id="gbm.-note-the-prominent-vascularity-as-well-as-the-area-of-necrosis-at-the-left-with-neoplastic-cells-palisading-around-it-pseudopalisading-necrosis." class="title-slide slide level1 center">
<h1>GBM. Note the prominent vascularity as well as the area of necrosis at the left with neoplastic cells palisading around it (pseudopalisading necrosis*).</h1>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri47.jpg"></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri48.jpg"></p>
<p><img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri49.jpg"></p>
</section>

<section id="here-is-an-ependymoma-arising-from-the-ependymal-lining-of-the-fourth-ventricle-above-the-brainstem-and-bulging-toward-the-cerebellum." class="title-slide slide level1 center">
<h1>Here is an ependymoma arising from the ependymal lining of the fourth ventricle above the brainstem and bulging toward the cerebellum.</h1>

<img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri50.jpg" class="r-stretch"></section>

<section id="this-horizontal-ct-scan-section-of-the-brain-reveals-a-large-ependymoma-of-the-fourth-ventricle." class="title-slide slide level1 center">
<h1>This horizontal (CT scan) section of the brain reveals a large ependymoma of the fourth ventricle.</h1>

<img data-src="img%5CSSS-T%C3%BCm%C3%B6rleri51.jpg" class="r-stretch"></section>

<section id="irregular-posterior-fossa-mass-medulloblastoma---near-the-midline-of-the-cerebellum-and-extending-into-the-fourth-ventricle-above-the-brainstem" class="title-slide slide level1 center">
<h1>Irregular posterior fossa mass (medulloblastoma) - near the midline of the cerebellum and extending into the fourth ventricle above the brainstem</h1>
<div class="footer footer-default">

</div>
</section>
    </div>
  </div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="sss-tumorleri_files/libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="sss-tumorleri_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="sss-tumorleri_files/libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="sss-tumorleri_files/libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="sss-tumorleri_files/libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="sss-tumorleri_files/libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="sss-tumorleri_files/libs/revealjs/plugin/notes/notes.js"></script>
  <script src="sss-tumorleri_files/libs/revealjs/plugin/search/search.js"></script>
  <script src="sss-tumorleri_files/libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="sss-tumorleri_files/libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': false,
'smaller': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: false,

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'none',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'default',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button', {
        text: function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
        }
      });
      clipboard.on('success', function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "Kopyalandı");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "Kopyalandı");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      });
      function tippyHover(el, contentFn) {
        const config = {
          allowHTML: true,
          content: contentFn,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start'
        };
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          return note.innerHTML;
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    

</body></html>